Latest Headlines

31. Aseptic Filling System OEM AST Announces Jason Rossi As Principal CQV Engineer 3/28/2025

    AST, a leading provider of flexible aseptic filling systems and drug manufacturing solutions, is pleased to announce the addition of Jason Rossi as Principal Commissioning, Qualification, and Validation Engineer. Jason will oversee site coordination, installation, and qualification of AST solutions, working in collaboration with AST customers onsite to ensure successful implementation of their equipment.

32. Chiesi Announces Plans To Build New Manufacturing Plant In Italy 3/28/2025

    Chiesi Group, a global biopharmaceutical company headquartered in Parma, Italy, has announced a major investment in Nerviano (Milan, Italy), with the construction of a new facility for the production of its therapeutic solutions. The project entails the revitalization of this historical production site, first established in 1965 as an oncology research centre for Farmitalia Carlo Erba and subsequently subjected to several ownership changes, until its closure in 2024.

33. CDMO Wheeler Bio Announces Plans To Build Out Large-Scale Biologics Manufacturing Facility In Oklahoma 3/25/2025
34. Upperton Pharma Solutions Wins Champion Award At 2025 CDMO Leadership Awards In Small Molecule Dosage Form Category 3/24/2025
35. Johnson & Johnson Announces $55 Billion Manufacturing Investment In United States 3/21/2025

    Johnson & Johnson, healthcare’s leading, most comprehensive innovation powerhouse, announced manufacturing, research and development, and technology investments of more than $55 billion in the United States over the next four years.

36. Upperton Continues Strategic Growth With The Appointment Of Michael Mellor-Clark As Chief Commercial Officer 3/20/2025

    Upperton Pharma Solutions, a leading UK-based contract development and manufacturing organisation (CDMO), continues its growth following the build of a new sterile manufacturing facility with the appointment of Michael Mellor-Clark as Chief Commercial Officer (CCO).

37. Entos Pharmaceuticals Announces Plans To Build $198M Facility In Alberta Canada 3/20/2025

    Entos® Pharmaceuticals (Entos), a clinical-stage genetic medicines company committed to using its Fusogenix™ PLV™ technology to develop cures, has announced a $62 million investment from the Government of Canada. This funding leverages a previously announced $15.5 million awarded to Entos from the Government of Alberta.

38. CDMO Delpharm Announces Plans To Upgrade Sterile Manufacturing Facility In Quebec 3/19/2025

    Delpharm, a world leader in pharmaceutical outsourcing, announced that it has reached an agreement with the Government of Canada to modernize its injectable manufacturing facility in Boucherville.

39. Aseptic Filling System Provider Announces New Chief Commercial Officer 3/17/2025

    AST, a leading provider of flexible aseptic filling systems, is pleased to announce an exciting addition to the Leadership team. Charisse Curtis has joined AST as Chief Commercial Officer, leading the Business Development, Marketing, and Communications teams. 

40. Körber And HighByte Partner To Accelerate The Digital Transformation Of Manufacturing In Life Sciences 3/17/2025

    Körber has officially certified HighByte Intelligence Hub for seamless integration with PAS-X MES as part of the Körber Ecosytem Partner Program. HighByte has achieved the “PAS-X MSI Plug & Produce” certification. This partnership empowers life sciences manufacturers to fast-track their digital transformation, enabling improved data visibility, enhanced operational agility, and increased manufacturing efficiency.